Back to search

Swarm Oncology Limited

14372453

active
ltd
england wales
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Negative net worth (-10)

Details

15 Stukeley Street (C/O Delin Ventures), London, WC2B 5LT
Incorporated 23/09/2022

Compliance

Last accounts

30/09/2024

total exemption full

Next accounts due

30/06/2026

On track

Confirmation statement

Last: 22/09/2025

Due 06/10/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Jonathan Russell Hay

director · Since 09/02/2023

British,American · United Kingdom · Age 64

Colin Freund

director · Since 12/10/2023

American · United States · Age 56

Miguel Forte

director · Since 29/01/2024

Portuguese · Belgium · Age 66

Martin Olin

director · Since 12/12/2024

Danish · Denmark · Age 57

Bernhard Rainer Maria Ehmer

director · Since 11/02/2026

German · Germany · Age 71

Former

Marshal Ungar

director · Resigned 09/02/2023

Colin Howard Sims

director · Resigned 06/10/2023

Lev Osherovich

director · Resigned 06/10/2023

Persons with Significant Control

Mr Igor Linshits

Significant control

British · Italy · Age 62

15, Stukeley Street (C/O Delin Ventures), London, WC2B 5LT

Notified 23/09/2022

Ekaterina Linshits

Significant control

British · England · Age 38

15, Stukeley Street (C/O Delin Ventures), London, WC2B 5LT

Notified 02/06/2025

Change History

statusactive
2026-06-06

Active

typeltd
2026-06-06

Private Limited Company

address line115 Stukeley Street (C/O Delin Ventures)
2026-06-06

15 STUKELEY STREET (C/O DELIN VENTURES)

post townLondon
2026-06-06

LONDON

officer appointedEHMER, Bernhard Rainer Maria
2026-06-06
officer appointedFORTE, Miguel, Dr
2026-06-06
officer appointedFREUND, Colin
2026-06-06
officer appointedHAY, Jonathan Russell
2026-06-06
officer appointedOLIN, Martin
2026-06-06

CompanyRankvs 1625+ SIC 72110 peers
50

Financial strength2th percentile among SIC peers · 1/25
Employees66th percentile among SIC peers · 10/15
LiquidityCurrent ratio 2.87× · 20/20
Longevity4 years trading (max 15) · 4/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength1/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity4/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/09/2024

Net Worth

-£2.3M

Balance sheet strength

Cash

£669k

Cash in the bank

Net Current Assets

£624k

Working capital

Current Assets

£957k

Current Liabilities

£333k

Fixed Assets

£208k

Debtors

£288k

Profit After Tax

-£1.5M

2avg. employees+1

Balance Sheet

Assets less current liabilities£832k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20242.87-£1.5M
202313.75

Derived from filed accounts. Not audited figures.